Related Experiment Video
Updated: Jul 15, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Yohimbine in the treatment of orgasmic dysfunction
Ade A Adeniyi1, Giles S Brindley, John P Pryor
1Institute of Urology and Nephrology, London W1P 7EY, UK.
Yohimbine effectively treated men with orgasmic dysfunction, with over half achieving orgasm. This medication offers a promising option for improving sexual function and addressing fertility concerns.
Area of Science:
- Urology
- Sexual Medicine
- Pharmacology
Background:
- Orgasmic dysfunction affects many men, impacting fertility and quality of life.
- Limited effective pharmacological treatments exist for orgasmic dysfunction.
Purpose of the Study:
- To evaluate the efficacy of yohimbine in treating men experiencing orgasmic dysfunction.
- To assess the safety and tolerability of yohimbine for this condition.
Main Methods:
- A clinical study involving 29 men diagnosed with orgasmic dysfunction of various causes.
- Initial yohimbine dosage of 20 mg, followed by patient-led dose titration at home.
- Assessment of treatment outcomes, including orgasm achievement and side effects.
Main Results:
- The study included men with primary complete, primary incomplete, and secondary orgasmic dysfunction.
- Overall, 62% of patients reported nocturnal emissions.
- Of the 29 participants, 16 achieved orgasm independently, and 3 required additional stimulation (vibrator).
- Two patients successfully fathered children, and three others reported a cure.
- Reported side effects did not lead to treatment discontinuation.
Conclusions:
- Yohimbine demonstrates utility as a treatment for men suffering from orgasmic dysfunction.
- The medication appears to be well-tolerated, with manageable side effects.
- Yohimbine may improve sexual function and contribute to successful conception in some cases.
Related Concept Videos
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Acting on Autonomic Ganglia: Blockers
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Antihypertensive Drugs: Vasodilators